Elevate Uranium Ltd (EL8) AI Stock Analysis

• Market Cap: AU$116.49M
• Dividend Yield: N/A
• Average Volume (3M): 1.69M
• Price to Earnings (P/E): ―
• Beta (1Y): 2.55
• Revenue Growth: N/A
• EPS Growth: 1.38%
• Country: AU
• Employees: N/A
• Sector: Energy
• Sector Strength: 52
• Industry: Uranium
• EPS (TTM): -0.01
• Shares Outstanding: 465,968,100
• 10 Day Avg. Volume: 1,984,434
• 30 Day Avg. Volume: 1,688,761
• PEG Ratio: 2.09
• Price to Book (P/B): 4.73
• Price to Sales (P/S): 147.04
• P/FCF Ratio: -9.65
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: AU$0.24 ▼(-29.12% Downside)
• Action: Reiterated Date: 03/24/26
• Date: Action: Reiterated 03/24/26

The score is primarily held back by weak financial performance (ongoing losses and negative operating/free cash flow) and bearish technical signals (trading below major moving averages with negative MACD). Valuation provides limited support because the company is loss-making and no dividend yield is available.

Positive Factors

Conservative leverage

A low debt-to-equity ratio and a stable equity ratio indicate conservative capital structure, reducing bankruptcy and interest burden risks. This durability supports multi-stage exploration financing and preserves strategic optionality as projects advance toward development or JV discussions.

Revenue improvement & gross margin

An increase in revenue alongside a positive gross profit margin suggests underlying operational efficiency on activities that generate cash. For a developer/explorer, this trend reduces reliance on purely dilutive funding and demonstrates some capacity to extract value from project activities over coming quarters.

Clear monetisation pathways

The company has explicit, established routes to monetize assets—develop into production, sign offtake, sell or joint-venture projects, or divest assets. These durable exit and funding mechanisms give strategic flexibility to advance value even if direct production timelines shift.

Negative Factors

Negative cash flow

Sustained negative operating and free cash flow signal ongoing cash burn and operational funding needs. Over a multi-month horizon this increases dependency on external financing, pressures liquidity and can delay exploration or studies if markets tighten or capital raises become more costly.

Unprofitable operations

Persistent negative net income and EBIT margins mean the company is not generating operational profits to fund growth. This undermines return on equity and requires continual external funding, limiting reinvestment capacity and raising execution risk for project advancement.

Funding dependence & dilution risk

As a pre-revenue exploration company that typically funds activities through equity raises, progress depends on access to capital markets. This creates recurring dilution risk for shareholders and introduces execution uncertainty if market conditions or investor appetite weaken over the next several months.

Elevate Uranium Ltd Business Overview & Revenue Model

Company Description

Elevate Uranium Ltd engages in the exploration and evaluation of uranium deposits. The company's principal projects include the Koppies, Hirabeb, Marenica, and Namib IV in Namibia. It also holds 100% interests in the Angela, Thatcher Soak, Oobagooma, and Minerva project areas, as well as the Bigrlyi, Malawiri, Walbiri, and Areva joint ventures in Australia. The company was formerly known as Marenica Energy Limited and changed its name to Elevate Uranium Ltd in May 2021. Elevate Uranium Ltd was incorporated in 1978 and is headquartered in West Perth, Australia.

How the Company Makes Money

Elevate Uranium is a pre-revenue minerals exploration and development company; it does not typically generate recurring operating revenue from selling products or services while it is exploring and evaluating deposits. If it were to make money, it would generally be through (i) developing a uranium project into production and selling uranium (e.g., U3O8) under offtake/sales contracts, and/or (ii) monetising assets by selling project interests, joint venturing projects, or selling the company, potentially along with any mineral rights/royalties. In practice, its funding is commonly sourced from capital raisings (issuing equity and/or other financing) to support exploration, studies, permitting, and project advancement. Specific details on current revenue streams, offtake agreements, or material revenue-generating partnerships are not available; therefore these items are null.

Elevate Uranium Ltd Financial Statement Overview

Summary

Revenue increased, but the company remains unprofitable with negative net income/EBIT margins and ongoing cash burn. The balance sheet is comparatively stable with low leverage, but negative ROE and weak cash generation keep the score low.

Income Statement

Elevate Uranium Ltd has shown a significant increase in revenue from 2024 to 2025, but the company remains unprofitable with negative net income and EBIT margins. The gross profit margin is positive, indicating some operational efficiency, but the overall profitability is weak due to high operating expenses.

Balance Sheet

The company maintains a low debt-to-equity ratio, suggesting conservative leverage. However, the return on equity is negative, reflecting ongoing losses. The equity ratio is relatively stable, indicating a solid capital structure despite profitability challenges.

Cash Flow

Operating and free cash flows are negative, indicating cash burn. The free cash flow growth rate is slightly negative, showing a small improvement. The cash flow to net income ratios suggest that cash flows are aligned with net losses, but the company needs to improve cash generation.

Breakdown	TTM	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement
Total Revenue	768.50K	768.50K	182.00	0.00	0.00	0.00
Gross Profit	813.11K	768.50K	-121.67K	-117.68K	-85.52K	-54.29K
EBITDA	-11.03M	-11.85M	-10.62M	-8.51M	-5.68M	-2.66M
Net Income	-10.99M	-12.32M	-10.75M	-8.63M	-5.73M	-2.60M
Balance Sheet
Total Assets	45.64M	25.46M	13.26M	12.54M	19.33M	9.96M
Cash, Cash Equivalents and Short-Term Investments	36.65M	21.71M	10.83M	10.06M	15.81M	6.66M
Total Debt	390.56K	432.41K	74.21K	146.03K	177.27K	99.29K
Total Liabilities	1.52M	1.57M	1.48M	1.02M	838.59K	429.54K
Stockholders Equity	44.12M	23.89M	11.78M	11.52M	18.49M	9.53M
Cash Flow
Free Cash Flow	-13.74M	-11.71M	-9.31M	-5.90M	-4.49M	-2.40M
Operating Cash Flow	-13.27M	-11.62M	-9.24M	-5.83M	-4.38M	-2.33M
Investing Cash Flow	-3.50M	-714.24K	-73.79K	-74.52K	-137.62K	-61.28K
Financing Cash Flow	23.13M	23.22M	10.09M	158.86K	13.67M	7.99M

Elevate Uranium Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.34
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:EL8, the sentiment is Negative. The current price of 0.34 is above the 20-day moving average (MA) of 0.32, below the 50-day MA of 0.36, and above the 200-day MA of 0.32, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 31.38 is Neutral, neither overbought nor oversold. The STOCH value of 9.70 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:EL8.

Elevate Uranium Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	65 Neutral	$15.17B	7.61	4.09%	5.20%	3.87%	-62.32%
PEN	46 Neutral	AU$230.85M	-2.14	-7.27%	―	-100.00%	49.49%
EME	46 Neutral	AU$18.66M	-30.09	-1.07%	―	―	8.33%
AEE	44 Neutral	AU$112.14M	-6.08	-17.88%	―	―	-75.25%
EL8	43 Neutral	AU$116.49M	-4.98	-32.33%	―	―	1.38%
BKY	43 Neutral	AU$174.05M	-16.35	-12.34%	―	―	-67.12%
ZEU	40 Underperform	AU$6.46M	-2.50	-82.81%	―	―	-141.67%

Elevate Uranium Ltd Corporate Events

Elevate Uranium Releases Half-Year Financial Report for December 2025

Elevate Uranium Ltd has released its half-year financial report for the period ended 31 December 2025, providing consolidated financial statements and accompanying notes. The report includes profit or loss and other comprehensive income, financial position, changes in equity, and cash flows, along with directors’ and auditors’ declarations, offering stakeholders a formal update on the company’s financial performance and position over the half year.

While detailed figures are not included in the release excerpt, the publication of the half-year report signals routine financial transparency and regulatory compliance for Elevate Uranium. This disclosure allows shareholders and potential investors to assess the company’s financial health, operational progress, and governance standards during a period of ongoing activity in the uranium and broader energy markets.

The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.32 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.

Elevate Uranium Builds Critical Mass With 153Mlb Global Resource Base

Elevate Uranium has outlined a global resource base of 153 million pounds of U3O8 across two top‑tier jurisdictions, positioning itself as an emerging mid‑tier player in the uranium sector. The company reports four discoveries in four years, including 96 million pounds of U3O8 linked to its proprietary U‑grade process, which could improve recoveries and costs as it moves projects from discovery toward development.

A further 57 million pounds of U3O8 is associated with multiple high‑grade prospects, offering diversification and exposure to targets above 1,000 ppm U3O8 that may support higher‑margin production. This growing resource inventory and exploration pipeline underpin Elevate Uranium’s strategy to build critical mass in a strengthening uranium market, potentially enhancing its appeal to investors seeking leveraged exposure to nuclear fuel demand.

The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.34 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.

Elevate Uranium Doubles Resource Grade at Namibia’s Marenica Project After Major Re-Estimate

Elevate Uranium has delivered a major upgrade to the Mineral Resource Estimate at its Marenica Uranium Project in Namibia, doubling the resource grade to 185 ppm U3O8 for 40.2 million pounds of contained uranium at a 100 ppm cut-off grade, and increasing the resource to 59 million pounds at 124 ppm U3O8 at a 50 ppm cut-off. The update, based on re-analysis of data from more than 5,000 historical drill holes and conversion of the resource to JORC 2012 standards, excludes some mineralised areas due to wide-spaced drilling, with infill programs set to begin this month to reintroduce those zones and upgrade parts of the resource from Inferred to Indicated, materially enhancing Marenica’s development potential and providing a more robust, lower-risk platform for Elevate’s growth ambitions in uranium.

The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.48 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.

Elevate Uranium Options Lapse, Clarifying Capital Structure

Elevate Uranium Ltd has confirmed the expiry of 14,904,798 listed options (ASX code EL8AT), which were due to expire on 30 January 2026 with an exercise price of A$0.60 and lapsed without being exercised. The cessation of these options reduces the company’s pool of potential future equity dilution but also removes a possible source of additional capital, clarifying the company’s current issued capital structure for existing shareholders and the market.

The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.48 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.

Elevate Uranium Options Lapse Simplifies Capital Structure

Elevate Uranium Ltd has confirmed that 14,904,798 unlisted Class EL8AT options, each exercisable at $0.60, expired on 30 January 2026. The lapse of these options marginally simplifies the company’s capital structure by removing a tranche of potential equity dilution from its balance of outstanding securities.

The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.48 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.

Elevate Uranium Managing Director Increases Indirect Shareholding via Super Fund

Elevate Uranium Limited has disclosed changes in the securities held by Managing Director Murray Hill and his related entities, including his spouse and their self-managed superannuation fund. The notice details a net acquisition of 1,349,486 fully paid ordinary shares in Elevate Uranium at a price of A$0.245 per share through the Carmu Super Fund account, offset by disposals from Hill personally and his spouse. While the transaction does not alter control of the company, it marginally increases Hill’s indirect equity exposure, which may be interpreted by investors as a vote of confidence in Elevate Uranium’s prospects and align the director’s financial interests more closely with those of shareholders.

The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.38 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.